SCHEMBL3052301

SCHEMBL3052301

CCCCOP(=O)([O-])OCCCC.CCCC[P+](CC)(CCCC)CCCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.49
CDC25A P30304 2/20 0.49
LMNA P02545 2/20 0.49
ESR1 P03372 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
AGTR1 P30556 1/20 0.49
ADRA1A P35348 1/20 0.49
KCNH2 Q12809 1/20 0.49
CYP3A4 P08684 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.42
PLA2G1B P04054 1/20 0.39
PLA2G2A P14555 1/20 0.39
PRKD3 O94806 1/20 0.38
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCI P41743 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3062759 0.92 AKT1 (0.51) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3070947 0.90 AKT1 (0.53) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3072185 0.90 AKT1 (0.55) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3073859 0.89 AKT1 (0.49) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3069306 0.89 AKT1 (0.53) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL14777198 0.87 AKT1 (0.56) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3309063 0.87 AKT1 (0.56) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3062058 0.87 AKT1 (0.56) AKT1CDC25ALMNAESR1ADORA3
Diethyl Hydrogen Phosphate SCHEMBL344448 0.87 CYP3A4 (0.43) AKT1CDC25ALMNAESR1ADORA3
SCHEMBL3066444 0.87 AKT1 (0.54) AKT1CDC25ALMNAESR1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540761-B1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2016-08-31 EP disclosed
US-8853346-B2 Curable resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-10-07 US disclosed
US-20130018168-A1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-01-17 US disclosed
EP-2540761-A1 CURABLE RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2013-01-02 EP disclosed
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2010-10-21 US disclosed
US-20090118442-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT ELL, RAD54L, RPP30 AKT1 2966/4885CDC25A 3722/4885LMNA 2696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.